Ovarian cancer trials in Peru

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  Where

  Castilla, Lima

  Age

  18 years and over

  People

  770 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06824467 · EU 2023-508015-23-00
• Phase 3Taking people
  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  Where

  Lima

  Age

  18 years and over

  People

  900 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07318558 · EU 2023-508047-40-00
• Phase 3Taking people
  Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer

  Where

  Arequipa, Lima, Wanchac

  Age

  18 years and over

  People

  950 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07851025 · EU 2026-526895-22-00
• Phase 3Taking people
  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  Where

  Lima

  Age

  18 years to 60 years

  People

  3,960 worldwide

  Run by

  NRG Oncology

  See details and how to joinNCT05879926